Published online before print January 18, 2007, doi: 10.1161/01.RES.0000258428.09589.1a
© 2007 American Heart Association, Inc.
Integrative Physiology |
Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation
From the From Department of Medicine and Research Center (S.C., P.P., S.L.B., A.S.-T., S.N.), Montreal Heart Institute and Université de Montréal, Departments of Pharmacology (S.C., S.N.) and Physiology (E.L., L.G.), McGill University, Montreal, McGill University and Genome Quebec Innovation Centre (A.P.) and INSERM U533-Institut du Thorax (N.L.M., J.L., S.D.), Nantes, France.
Correspondence to Stanley Nattel, Montreal Heart Institute, 5000 Belanger St. E., Montreal, Quebec, Canada, H1T 1C8. E-mail stanley.nattel{at}icm-mhi.org
Gene-expression changes in atrial fibrillation patients reflect both underlying heart-disease substrates and changes because of atrial fibrillation-induced atrial-tachycardia remodeling. These are difficult to separate in clinical investigations. This study assessed time-dependent mRNA expression-changes in canine models of atrial-tachycardia remodeling and congestive heart failure. Five experimental groups (5 dogs/group) were submitted to atrial (ATP, 400 bpm x24 hours, 1 or 6 weeks) or ventricular (VTP, 240 bpm x24 hours or 2 weeks) tachypacing. The expression of 
21,700 transcripts was analyzed by microarray in isolated left-atrial cardiomyocytes and (for 18 genes) by real-time RT-PCR. Protein-expression changes were assessed by Western blot. In VTP, a large number of significant mRNA-expression changes occurred after both 24 hours (2209) and 2 weeks (2720). In ATP, fewer changes occurred at 24 hours (242) and fewer still (87) at 1 week, with no statistically-significant alterations at 6 weeks. Expression changes in VTP varied over time in complex ways. Extracellular matrix-related transcripts were strongly upregulated by VTP consistent with its pathophysiology, with 8 collagen-genes upregulated >10-fold, fibrillin-1 8-fold and MMP2 4.5-fold at 2 weeks (time of fibrosis) but unchanged at 24 hours. Other extracellular matrix genes (eg, fibronectin, lysine oxidase-like 2) increased at both time-points (10, 5-fold respectively). In ATP, mRNA-changes almost exclusively represented downregulation and were quantitatively smaller. This study shows that VTP-induced congestive heart failure and ATP produce qualitatively different temporally-evolving patterns of gene-expression change, and that specific transcriptomal responses associated with atrial fibrillation versus underlying heart disease substrates must be considered in assessing gene-expression changes in man.
Key Words: arrhythmia • remodeling • genomic
This article has been cited by other articles:
 |
|
 |
|
  K. Nishida, G. Michael, D. Dobrev, and S. Nattel Animal models for atrial fibrillation: clinical insights and scientific opportunities Europace, October 29, 2009; (2009) eup328v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shan, Y. Zhang, Y. Lu, Y. Zhang, Z. Pan, B. Cai, N. Wang, X. Li, T. Feng, Y. Hong, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines Cardiovasc Res, August 1, 2009; 83(3): 465 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Kort, P. Norton, P. Haak, B. Berghuis, S. Ramirez, and J. Resau Review Paper: Gene Expression Profiling in Veterinary and Human Medicine: Overview of Applications and Proposed Quality Control Practices Vet. Pathol., July 1, 2009; 46(4): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maguy, S. Le Bouter, P. Comtois, D. Chartier, L. Villeneuve, R. Wakili, K. Nishida, and S. Nattel Ion Channel Subunit Expression Changes in Cardiac Purkinje Fibers: A Potential Role in Conduction Abnormalities Associated With Congestive Heart Failure Circ. Res., May 8, 2009; 104(9): 1113 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel Effects of Heart Disease on Cardiac Ion Current Density Versus Current Amplitude: Important Conceptual Subtleties in the Language of Arrhythmogenic Ion Channel Remodeling Circ. Res., June 6, 2008; 102(11): 1298 - 1300. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nattel, B. Burstein, and D. Dobrev Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 62 - 73. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Burstein, E. Libby, A. Calderone, and S. Nattel Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences Circulation, April 1, 2008; 117(13): 1630 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Burstein and S. Nattel Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation J. Am. Coll. Cardiol., February 26, 2008; 51(8): 802 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Burstein, X.-Y. Qi, Y.-H. Yeh, A. Calderone, and S. Nattel Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling Cardiovasc Res, December 1, 2007; 76(3): 442 - 452. [Abstract] [Full Text] [PDF]
|
|